Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05182_nanopub.RAxmBoGYmZUHSpRpG70TDa4w8W_6AS3mZmIQI-USVsTVE#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05182 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05182 label "AS1409 [drugbank:DB05182]" assertion.
- drugbank:DB05182 seeAlso DB05182 assertion.
- drugbank:DB05182 description "AS1409 is a genetically engineered fusion protein made up of two distinct components. One is the cytokine IL12, which has anti-cancer activity. The other is an antibody that targets tumours. It is developed by Antisoma is in a phase I of clinical trial for the treatment of renal cancer and melanoma." assertion.
- drugbank:DB05182 identifier "drugbank:DB05182" assertion.
- drugbank:DB05182 title "AS1409" assertion.
- drugbank:DB05182 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05182 drugbank_vocabulary:drugbank-id "DB05182" assertion.
- drugbank:DB05182 bio2rdf_vocabulary:x-identifiers.org DB05182 assertion.
- drugbank:DB05182 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05182" assertion.
- drugbank:DB05182 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05182 bio2rdf_vocabulary:identifier "DB05182" assertion.